Alkermes plc (ALKS)
NASDAQ: ALKS · Real-Time Price · USD
29.80
-0.24 (-0.80%)
At close: Oct 24, 2025, 4:00 PM EDT
29.85
+0.05 (0.17%)
After-hours: Oct 24, 2025, 5:05 PM EDT
Alkermes Market Cap
Alkermes has a market cap or net worth of $4.92 billion as of October 24, 2025. Its market cap has increased by 12.35% in one year.
Market Cap
4.92B
Enterprise Value
3.98B
1-Year Change
12.35%
Ranking
Category
Stock Price
$29.80
Market Cap Chart
Since December 1, 1998, Alkermes's market cap has increased from $383.70M to $4.92B, an increase of 1,182.08%. That is a compound annual growth rate of 9.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 24, 2025 | 4.92B | 5.71% |
| Dec 31, 2024 | 4.65B | 0.52% |
| Dec 29, 2023 | 4.63B | 7.82% |
| Dec 30, 2022 | 4.29B | 14.15% |
| Dec 31, 2021 | 3.76B | 18.47% |
| Dec 31, 2020 | 3.18B | -1.20% |
| Dec 31, 2019 | 3.21B | -29.92% |
| Dec 31, 2018 | 4.59B | -45.52% |
| Dec 29, 2017 | 8.42B | -0.36% |
| Dec 30, 2016 | 8.45B | -29.09% |
| Dec 31, 2015 | 11.91B | 39.10% |
| Dec 31, 2014 | 8.56B | 53.99% |
| Dec 31, 2013 | 5.56B | 127.59% |
| Dec 31, 2012 | 2.44B | 8.61% |
| Dec 30, 2011 | 2.25B | 91.59% |
| Dec 31, 2010 | 1.17B | 31.68% |
| Dec 31, 2009 | 891.70M | -12.16% |
| Dec 31, 2008 | 1.02B | -36.29% |
| Dec 31, 2007 | 1.59B | 18.17% |
| Dec 29, 2006 | 1.35B | -22.92% |
| Dec 30, 2005 | 1.75B | 37.76% |
| Dec 31, 2004 | 1.27B | 5.23% |
| Dec 31, 2003 | 1.21B | 197.29% |
| Dec 31, 2002 | 405.90M | -76.06% |
| Dec 31, 2001 | 1.70B | -2.38% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 741.04B |
| Johnson & Johnson | 457.77B |
| AbbVie | 402.76B |
| UnitedHealth Group | 328.31B |
| AstraZeneca | 258.55B |
| Novartis AG | 253.40B |
| Novo Nordisk | 236.76B |
| Abbott Laboratories | 220.78B |